Theranostics News and Research

RSS

Global nuclear medicine community shares approaches to contain the spread of COVID-19

In an effort to provide safer working environments for nuclear medicine professionals and their patients, clinics across five continents have shared their approaches to containing the spread of COVID-19 in a series of editorials, published ahead of print in The Journal of Nuclear Medicine.

1 Apr 2020

Total-body PET provides suitable images of antibodies up to 30 days after injection

Combining 89Zr-labeled antibodies with total-body positron emission tomography (PET) has extended the utility of novel total-body PET scanners, providing suitable images up to 30 days after the initial injection.

31 Mar 2020

Novel PET/CT systems provide quantitative assessment of brain stem nuclei in patients with hearing loss

Novel, fully digital, high-resolution positron emission tomography/computed tomography (PET/CT) imaging of small brain stem nuclei can provide clinicians with valuable information concerning the auditory pathway in patients with hearing impairment, according to a new study published in the March issue of The Journal of Nuclear Medicine.

25 Mar 2020

New nanoparticle nickel-based contrast agent for photoacoustic imaging of deep tissues

Photoacoustic imaging has gained global attention for capturing images without causing pains or using ionizing radiation. Recently, many researchers have heavily studied on observing deep tissues to apply the photoacoustic imaging to clinical diagnosis and practices.

6 Mar 2020

PET imaging helps researchers to detect transplant patients with cardiac allograft vasculopathy

Myocardial blood flow and myocardial flow reserve have been identified as accurate indicators for graft failure after cardiac transplantation, according to a new study published in The Journal of Nuclear Medicine.

5 Mar 2020

Researchers identify major landmarks of peripheral artery disease recovery

Novel biomedical advances that show promise in the lab often fall short in clinical trials. For researchers studying peripheral artery disease, this is made more difficult by a lack of standardized metrics for what recovery looks like.

2 Mar 2020

Study suggests potential therapy option for early-stage breast cancer

Radionuclide therapy has proven successful in delaying the growth of disseminated tumor cells (DTCs) in early-stage breast cancer in a small animal model, suggesting its use as a potential adjuvant therapy for retarding the proliferation of DTCs.

5 Feb 2020

PET/MRI identifies potentially useful breast cancer biomarkers

Researchers have identified several potentially useful breast cancer biomarkers that indicate the presence and risk of malignancy, according to new research published in the January issue of The Journal of Nuclear Medicine.

22 Jan 2020

Study of glycobiology and glycan diagnostics in personalized medicine featured in OMICS special issue

An in-depth look at the science of glycobiology and glycan diagnostics, and their promise in personalized medicine in the current post-genomic era are featured in a special issue of OMICS: A Journal of Integrative Biology, the peer-reviewed interdisciplinary journal published by Mary Ann Liebert, Inc., publishers.

13 Jan 2020

New radiotracer can provide insights into how the heart recovers after myocardial infarction

Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage.

2 Jan 2020

Finding non-invasive nuclear medicine technique to predict effectiveness of therapy for tumors

Researchers have taken a critical step toward developing a non-invasive nuclear medicine technique that can predict the effectiveness of therapy for cancerous tumors, allowing for personalized, precision treatment.

13 Dec 2019

Imaging technique and machine learning may provide accurate diagnosis of colorectal cancer

Colorectal cancer is the second most common type of cancer worldwide, with about 90% of cases occurring in people 50 or older.

5 Dec 2019

New theranostic reagent could improve detection and treatment of prostate cancer

A recently discovered prostate cancer-selective antigen has been identified as a useful molecular imaging target for the detection and targeting of metastatic prostate cancer lesions, as reported in the November issue of The Journal of Nuclear Medicine.

27 Nov 2019

Patient-specific dosimetry can improve treatment for neuroendocrine tumors

In neuroendocrine tumor treatment, different methods of predicting patient response may be required for different patients, according to new research published in the October issue of The Journal of Nuclear Medicine. By tailoring the method to the specific patient, physicians may better predict the effectiveness of treatment.

30 Oct 2019

New way to detect and attack cancer cells using solar technology

Scientific breakthroughs don't always happen in labs. For Sophia and Richard Lunt, Michigan State University researchers, many of their breakthroughs happen during neighborhood walks.

25 Oct 2019

Novel noninvasive imaging technique can provide information about thyroid disorders

A combination of multispectral optoacoustic tomography (MSOT) and ultrasound has been used to noninvasively characterize a range of thyroid disorders, according to new research published in the October issue of The Journal of Nuclear Medicine.

23 Oct 2019

New method may offer effective treatment for pancreatic cancer with fewer side effects

Pancreatic cancer is one of the leading causes of cancer-related deaths worldwide. Patients with pancreatic cancer often receive chemotherapy or radiation therapy, which are not always effective and can have toxic side effects.

21 Oct 2019

Study evaluates role of PET/CT in selecting candidates for peptide receptor radionuclide therapy

A new study published in The Journal of Nuclear Medicine evaluated the role of 68Ga-DOTATATE positron emission tomography/computed tomography in selecting neuroendocrine tumor patients who may benefit from peptide receptor radionuclide therapy.

9 Oct 2019

Chemists develop new approach based on graphene nanoflakes for drug delivery

Chemists funded by the SNSF have created a new compound for flexible drug delivery that specifically targets prostate cancer cells. Incorporating four different molecules, the compound prevents tumor cells from multiplying, can be detected by medical imaging and has staying power in the bloodstream.

19 Aug 2019

Ultrasensitive method for direct detection of circulating tumor cells in blood

Tumor cells circulating in blood are markers for the early detection and prognosis of cancer. However, detection of these cells is challenging because of their scarcity.

8 Aug 2019